PCP (Phencyclidine) Effects on the Brain: NMDA Receptor Antagonism
Phencyclidine (PCP, "angel dust") is a non-competitive antagonist at the NMDA subtype of glutamate receptor (N-methyl-D-aspartate receptor).
Primary Neuropharmacology
- Binds inside the NMDA receptor ion channel (phencyclidine binding site) → blocks cation (Ca²⁺, Na⁺) influx.
- Disrupts glutamatergic neurotransmission → alters synaptic plasticity, learning, memory.
- Key regions: cerebral cortex (cognition, perception), hippocampus (memory), amygdala (emotion, fear).
- Also affects dopamine, norepinephrine, serotonin, sigma, and nicotinic receptors.
Acute Effects
- Dissociation (detachment from self/environment), hallucinations, delirium.
- Ataxia, nystagmus, hypertension, tachycardia.
- Agitation, aggression, analgesia (risk of self-injury).
- Seizures, rhabdomyolysis, hyperthermia at high doses.
Chronic Effects
- Cognitive impairment (memory, executive function), persistent psychosis, mood disorders.
- Structural brain changes (cortical atrophy, white matter abnormalities).
PCP's NMDA blockade underlies its unique dissociative anesthetic and psychotomimetic profile. No specific antidote; management is supportive.
Brain & Nervous System - Related Articles
- Conscious vs. Subconscious Mind: Differences, Interaction, and Access Techniques
- Understanding and Caring for Individuals with Huntington's Disease
- Recognizing Closed Head Injuries: Symptoms & Treatment
- Subconscious vs. Unconscious: Psychological Distinctions
- "Butterflies in the Stomach": Causes, Triggers, and When to Worry
- Accessory Nerve (Cranial Nerve XI): Definition & Function
- The Twelve Cranial Nerves: Complete Anatomical List
